SCHEMBL24344138

SCHEMBL24344138

COCCc1cnc2c(O)c(C)ccn2c1=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ TP53 P04637 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ POLB P06746 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TLR7 Q9NYK1 1/20 0.32
▸ CASP1 P29466 2/20 0.32
▸ CASP7 P55210 2/20 0.32
▸ GBA1 P04062 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10027311 0.85 MAPT (0.36) HSD17B10ALDH1A1KDM4EHPGDTP53
SCHEMBL17808787 0.83 ACVR1 (0.48) HSD17B10ALDH1A1KDM4EHPGDHTT
SCHEMBL17808853 0.81 KDM4E (0.39) HSD17B10ALDH1A1KDM4EHPGDHTT
SCHEMBL17808907 0.78 CYP2C9 (0.43) HSD17B10ALDH1A1KDM4EHPGDMAPT
SCHEMBL10027310 0.77 ALDH1A1 (0.35) HSD17B10ALDH1A1KDM4EHPGDTP53
SCHEMBL19361118 0.73 AURKA (0.36) HSD17B10TP53MAPTLMNA
SCHEMBL19365017 0.72 KDM5A (0.37) ALDH1A1KDM4EHPGDTP53MAPT
SCHEMBL17808847 0.72 KDM4E (0.60) HSD17B10ALDH1A1KDM4EHPGDHTT
SCHEMBL17808732 0.71 MAPT (0.36) ALDH1A1KDM4EHPGDHTTTP53
SCHEMBL10027189 0.71 LMNA (0.34) HSD17B10TP53MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227292-B1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS ALTERITY THERAPEUTICS LTD (AU) 2022-03-09 — — EP disclosed
Send feedback